Open-chain half-bastadins mimic the effects of cyclic bastadins on calcium homeostasis in cultured neurons

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 21, 2008, Pages 5734-5737

  Zieminska, Elzbieta ^a   Lazarewicz, Jerzy W ^a   Couladouros, Elias A ^b,c   Moutsos, Vassilios I ^c   Pitsinos, Emmanuel N ^c  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^c Institute of Physical Chemistry   (Greece)

Author keywords

Bastadins; Calcium channels; Cerebellar granule cells; Diaryl ether; Ryanodine

Indexed keywords

BASTADIN 5; BASTADIN DERIVATIVE; CALCIUM; NATURAL PRODUCT; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; DRUG STRUCTURE; DRUG SYNTHESIS; NERVE CELL CULTURE; NONHUMAN; RAT; STRUCTURE ANALYSIS;

ANIMALS; CALCIUM; CELLS, CULTURED; CYCLIZATION; HALOGENATED DIPHENYL ETHERS; HOMEOSTASIS; NEURONS; PROTEIN CONFORMATION; RATS;

EID: 54049157139     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.09.080     Document Type: Article

References (23)

1. Clapham D.E. Cell 80 (1995) 259
2. Zucchi R., and Ronca-Testoni S. Pharmacol. Rev. 49 (1997) 1
3. Berchtold M.W., Brinkmeier H., and Müntener M. Physiol. Rev. 80 (2000) 1215
4. Mattson M.P. Aging Cell 6 (2007) 337
5. Peng J., Li J., and Hamann M. The Alkaloids: Chemistry and Biology 61 (2005) 59
6. Mack M.M., Molinski T.F., Buck E.D., and Pessah I.N. J. Biol. Chem. 269 (1994) 23236
7. Franklin M.A., Penn S.G., Lebrilla C.B., Lam T.H., Pessah I.N., and Molinski T.F. J. Nat. Prod. 59 (1996) 1121
8. DiJulio D.H., Watson E.L., Pessah I.N., Jacobson K.L., Ott S.M., Buck E.D., and Singh J.C. J. Biol. Chem. 272 (1997) 15687
9. Pessah I.N., Molinski T.F., Meloy T.D., Wong P., Buck E.D., Allen P.D., Mohr F.C., and Mack M.M. Am. J. Physiol. 272 (1997) C601
10. Chen L., Molinski T.F., and Pessah I.N. J. Biol. Chem. 274 (1999) 32603
11. González A., Kirsch W.G., Shirokova N., Pizarro G., Brum G., Pessah I.N., Stern M.D., Cheng H., and Rios E. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4380
12. Couladouros E.A., and Moutsos V.I. Tetrahedron Lett. 40 (1999) 7023
13. Couladouros E.A., and Moutsos V.I. Tetrahedron Lett. 40 (1999) 7027
14. Couladouros E.A., Moutsos V.I., and Pitsinos E.N. ARKIVOC 15 (2003) 92
15. Couladouros E.A., Pitsinos E.N., Moutsos V.I., and Sarakinos G. Chem. Eur. J. 11 (2005) 406
16. Masuno M.N., Pessah I.N., Olmstead M.M., and Molinski T.F. J. Med. Chem. 49 (2006) 4497
17. Zieminska E., Stafiej A., Pitsinos E.N., Couladouros E.A., Moutsos V., Kozlowska H., Toczylowska B., and Lazarewicz J.W. Neurosignals 15 (2006-2007) 283
18. 6Na requires 756.96710.
19. 8 The cells were used for experiments on the 7th day in vitro.
20. 8
21. 2 (1 μCi/well) was added together with tested compounds for 10 min. Then the medium was removed and the cells were washed, dissolved in 0.5 M NaOH, and radioactivity in neurons was measured with a Wallac 1409 liquid scintillation counter as described in Makarewicz, D.; Zieminska, E.; Lazarewicz, J. W. Neurochem. Int. 2003, 43, 273.
22. Ryanodine and FK506 had similar effects on the activity of compound 2b (Fig. S1 in Supplementary data).
23. Gafni J., Wong P.W., and Pessah I.N. Toxicol. Sci. 77 (2004) 72